Skip to main content
TipRanks
Go Ultimate75% OFF

Actinogen Medical (3AC) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

3AC Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Actinogen Medical in the past 3 months

3AC Stock 12 Month Forecast

€0.05▲(105.58% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Actinogen Medical in the last 3 months. The average price target is EUR 0.05 with a high forecast of EUR 0.05 and a low forecast of EUR 0.05. The average price target represents a 105.58% change from the last price of EUR 0.02.
Highest Price Target€0.05Average Price Target€0.05Lowest Price Target€0.05

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:3AC
Price TargetArticle
Canaccord Genuity€0.05buy105.58%UpsideReiterated09/03/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Actinogen Medical

3 Months
Shane Storey
Shane StoreyCanaccord Genuity
Success Rate1/4 ratings generated profit
25%
Average Return
+190.10%

Copying Shane Storey's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +190.10% per trade.

1 Year
Shane Storey
Shane StoreyCanaccord Genuity
Success Rate0/5 ratings generated profit
0%
Average Return
-16.98%

Copying Shane Storey's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.98% per trade.

2 Years
Shane Storey
Shane StoreyCanaccord Genuity
Success Rate0/5 ratings generated profit
0%
Average Return
-16.98%

Copying Shane Storey's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -16.98% per trade.

3AC Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 3AC
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11211
Buy00000
Hold00000
Sell00000
Strong Sell00000
total11211

In the current month, 3AC has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 3AC average Analyst price target in the past 3 months is 0.05.

3AC Financial Forecast

€-2€-1.5€-1€-0.5€0Q4 2025Q4 2026Q2 2027
Consensus€-0.00

3AC Earnings Forecast

Next quarter’s earnings estimate for 3AC is EUR 0.00 with a range of ― to ―. The previous quarter’s EPS was EUR 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€-1€-0.5€0€0.5€1Q4 2025Q4 2026Q2 2027
Consensus€0.00

3AC Sales Forecast

Next quarter’s sales forecast for 3AC is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

3AC Stock Forecast FAQ

What is DE:3AC’s average 12-month price target, according to analysts?
Based on analyst ratings, Actinogen Medical ’s 12-month average price target is €0.05.
What is DE:3AC’s upside potential, based on the analysts’ average price target?
Actinogen Medical has 105.58% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Actinogen Medical a Buy, Sell or Hold?
Actinogen Medical has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Actinogen Medical ’s share price target?
The average share price target for Actinogen Medical is €0.05. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €0.05, and the lowest forecast is €0.05. The average share price target represents a 105.58% increase from the current price of €0.024.
What do analysts say about Actinogen Medical ?
Actinogen Medical ’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Actinogen Medical ?
To buy shares of DE:3AC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.